Kronox Lab Sciences Limited

Kronox Lab Sciences: AGM Approves Financials, Dividend, Director Re-appointment, and Cost Auditor Remuneration

Kronox Lab Sciences Limited's 17th AGM on September 16, 2026, saw all resolutions passed. Key approvals include adopting FY26 standalone financials, declaring a final dividend of ₹0.50 per share for FY25-26, re-appointing a director, and ratifying cost auditor remuneration for FY26-27.

Kronox Lab Sciences Ltd. AGM Voting Results: All Resolutions Passed, Final Dividend Approved

Kronox Lab Sciences Limited's AGM on September 16, 2026, saw all resolutions passed. Shareholders approved the FY26 standalone financial statement and a final dividend of ₹0.50 per share for FY25-26. The re-appointment of a director and cost auditor remuneration were also ratified.

Kronox Lab Sciences Holds 17th AGM on Sep 16, 2026; Dividend Declared

Kronox Lab Sciences held its 17th AGM on September 16, 2026. The company declared a final dividend of ₹0.50 per equity share for FY 2025-26. The audited financial statements for FY 2025-26 were adopted. Voting results will be announced by September 18, 2026.

Kronox Lab Sciences Limited receives Draft Letter of Offer for Open Offer

Kronox Lab Sciences Limited announced receipt of a Draft Letter of Offer (DLOF) for an open offer. Indo Borax and Chemicals Limited, along with Zenrock Chemicals Private Limited, plan to acquire up to 95,70,000 equity shares at ₹157.27 per share, representing 25.79% of voting capital. The offer commences on October 15, 2026, and closes on October 29, 2026.

Kronox Lab Sciences Announces 17th AGM on Sep 16, 2026

Kronox Lab Sciences Limited will hold its 17th Annual General Meeting on Wednesday, September 16, 2026, at 11:00 AM via Video Conferencing. The notice was published in The Indian Express and Financial Express on August 26, 2026.

Kronox Lab Sciences: Open Offer Detailed Public Statement Published

Kronox Lab Sciences Limited announced the publication of a Detailed Public Statement for an open offer to acquire equity shares. The statement was published on August 28, 2026, in various newspapers. IIFL Capital Services is managing the offer for Indo Borax and Chemicals Limited.

Kronox Lab Sciences Fixes Sept 9, 2026 as Record Date for Final Dividend

Kronox Lab Sciences Limited has fixed September 09, 2026, as the record date for its final dividend. The company recommended a final dividend of ₹0.50 per equity share for FY 2025-26. This is to determine shareholder eligibility for the dividend payment.

Kronox Lab Sciences to Hold 17th AGM on Sept 16, 2026; Proposes Dividend

Kronox Lab Sciences will hold its 17th AGM on September 16, 2026, via VC/OAVM. The agenda includes adopting FY26 financials and declaring a final dividend of ₹0.50 per share for FY26. The re-appointment of director Jogindersingh Jaswal and ratification of cost auditor remuneration are also on the agenda.

Indo Borax & Chemicals to acquire 25.79% stake in Kronox Lab Sciences via Open Offer

Indo Borax & Chemicals Limited, along with Zenrock Chemicals Private Limited, is launching an open offer to acquire up to 25.79% of Kronox Lab Sciences Limited for ₹1,505.07 crore at ₹157.27 per share. This follows a Share Purchase Agreement to acquire 64.26% for ₹2,461.18 crore.

Kronox Lab Sciences Promoters Sell 64.26% Stake for ₹103.22/share

Kronox Lab Sciences promoters are selling 64.26% stake for ₹103.22 per share via SPA dated August 20, 2026. Indo Borax & Chemicals Limited is the acquirer. A mandatory tender offer to public shareholders will follow. This results in a change of promoters and control.

Kronox Lab Sciences Promoters Sell 64.26% Stake to Indo Borax for ₹2463 Crore

Promoters of Kronox Lab Sciences Limited have agreed to sell 64.26% stake to Indo Borax & Chemicals Limited for approximately ₹2,463 crore. The deal involves 2,38,44,000 equity shares at ₹103.22 per share. A mandatory tender offer to public shareholders will follow. This transaction leads to a change in promoters and control.

Kronox Lab Sciences Announces Newspaper Publication of Unaudited Financial Results for Q2 FY26

Kronox Lab Sciences Limited has published its unaudited financial results for the quarter ended June 30, 2026. The results were advertised in the Indian Express and Financial Express on August 14, 2026, as per SEBI regulations.

Kronox Lab Sciences Sets Record Date for Final Dividend Payment and AGM on Sep 9, 2026

Kronox Lab Sciences has set September 9, 2026, as the record date for its final dividend payment for FY25-26. The book closure will be from September 10 to September 16, 2026. The dividend is pending approval at the 17th AGM scheduled for September 16, 2026.

Kronox Lab Sciences Approves Q1 FY26 Results, Sets AGM for Sep 16

Kronox Lab Sciences approved its Unaudited Standalone Financial Results for Q1 FY26, reporting total income of ₹2,968.3 Lakhs. The 17th AGM is scheduled for September 16, 2026, with the register of members closed from September 10-16. Internal and Cost Auditors were re-appointed for FY27.

Kronox Lab Sciences Board Approves Q1 FY26 Results, Sets AGM for Sep 16

Kronox Lab Sciences approved Q1 FY26 standalone results with total income of ₹2,968.3 Lakhs and profit before tax of ₹981.0 Lakhs. The 17th AGM is scheduled for September 16, 2026, with book closure from September 10-16. Internal and Cost Auditors were re-appointed for FY 2026-27.

Kronox Lab Sciences Clarifies Significant Increase in Share Volume

Kronox Lab Sciences Limited has addressed a significant increase in its share trading volume. The company stated that it has complied with all disclosure regulations and that the management is not connected to the volume surge. Kronox reiterated its commitment to compliance.

Kronox Lab Sciences submits SEBI Reg 74(5) Certificate for Q1FY27

Kronox Lab Sciences Limited submitted its SEBI Regulation 74(5) certificate for the quarter ended June 30, 2026. The company received the confirmation from its Registrar and Share Transfer Agent, Kfin Technologies Limited, regarding the dematerialization/rematerialization of securities.

Kronox Lab Sciences Limited Publishes Audited Financial Results for FY26

Kronox Lab Sciences Limited announced its audited financial results for FY26. Total Revenue from Operations for the year ended March 31, 2026, was ₹11,694.71 Lakh. Profit Before Tax was ₹389.19 Lakh, and Profit for the period was ₹169.29 Lakh. Diluted EPS for the year was ₹0.24.

Kronox Lab Sciences Recommends ₹0.50 Dividend, Approves Audited Results for FY26

Kronox Lab Sciences approved audited standalone results for the quarter and year ended March 31, 2026. The Board recommended a dividend of ₹0.50 per share. Total income for FY26 was ₹10,641.40 Lakhs, and profit after tax was ₹2,766.00 Lakhs. The earnings per share (EPS) for the year is ₹7.51.

Kronox Lab Sciences Approves Audited FY26 Results and Recommends 5% Dividend

Kronox Lab Sciences reported audited standalone results for Q4FY26 and FY26. For Q4FY26, revenue from operations was ₹26.13 crore and profit after tax was ₹8.00 crore. For FY26, revenue from operations was ₹101.22 crore and profit after tax was ₹27.66 crore. The Board recommended a final dividend of 5% (₹0.50 per share).

Kronox Lab Sciences Clarifies Price Movement, Cites Market Driven Factors

Kronox Lab Sciences Limited has clarified a significant movement in its share price, stating it is market-driven and not connected to management actions. The company assures continued compliance with SEBI regulations regarding disclosure of material information.

Kronox Lab Sciences Files SEBI Regulation 74(5) Certificate for Q4FY26

Kronox Lab Sciences Limited submitted its SEBI Regulation 74(5) certificate for the quarter ended March 31, 2026. The company's Registrar and Share Transfer Agent, Kfin Technologies Limited, confirmed the furnishing of dematerialization/rematerialization details to stock exchanges.

Kronox Lab Sciences Publishes Q3 FY26 Unaudited Financial Results

Kronox Lab Sciences Limited announced its unaudited financial results for the quarter ended December 31, 2025. Consolidated total income was ₹10.58 crore with a net profit after tax of ₹6.10 crore. Standalone total income was ₹10.58 crore with a net profit after tax of ₹5.22 crore. Nine-month consolidated income was ₹37.18 crore (net profit ₹46.19 crore), and standalone income was ₹46.04 crore (net profit ₹68.15 crore).

Kronox Lab Sciences Q3FY26 Standalone Revenue at ₹2,527.40 Lakhs

Kronox Lab Sciences reported standalone un-audited financial results for the quarter ended December 31, 2025. Revenue from operations was ₹2,527.40 Lakhs, and Profit After Tax was ₹658.90 Lakhs. For the nine months ended December 31, 2025, revenue was ₹7,509.37 Lakhs, with Profit After Tax at ₹1,965.79 Lakhs.

Kronox Lab Sciences: Trading Window to Close from Jan 1, 2026

Kronox Lab Sciences Limited will close its trading window from January 1, 2026, for designated persons. The window will reopen 48 hours after the announcement of the Q3 FY26 financial results. The date for the board meeting to approve these results will be announced later.

Kronox Lab Sciences: Trading Window Closed Dec 1, 2026 for Financial Results

Kronox Lab Sciences will close its trading window from December 1, 2026, for designated persons. The window will reopen 48 hours after the announcement of Q3 FY26 and nine-month FY26 financial results, pending board approval.

Newspaper Publication of Unaudited Financial Results

Kronox Lab Sciences Limited announced the publication of unaudited financial results for the quarter ended September 30, 2025, in Indian Express and Financial Express on November 13, 2025, in compliance with SEBI regulations.

Kronox Lab Sciences Board Approves Q2 & H1 FY26 Standalone Unaudited Financial Results

Kronox Lab Sciences approved Q2 and H1 FY26 standalone unaudited financial results. Q2 PAT rose to ₹874.29 lakhs and H1 PAT to ₹1306.69 lakhs, showing positive growth.

Kronox Lab Sciences Approves Unaudited Financial Results for Quarter Ended Sep 30, 2025

Kronox Lab Sciences approved standalone unaudited financial results for the quarter and half year ended 30 September 2025. Total income for the quarter was ₹2,515.97 lakhs and profit after tax was ₹624.21 lakhs.

Kronox Lab Sciences Receives Consent to Establish for Unit-IV

Kronox Lab Sciences received necessary approvals, including GPCB consent, to begin construction of Unit-IV at Dahej. Construction will start soon.

Kronox Lab Sciences Submits Regulation 74(5) Certificate for Q3 FY25

Kronox Lab Sciences submitted the Regulation 74(5) certificate for the quarter ended September 30, 2025, confirming dematerialization/rematerialization details to exchanges.

Kronox Lab Sciences Secures Environmental Clearance for Dahej Unit-IV Construction

Kronox Lab Sciences Holds 16th AGM, Declares ₹0.50 Dividend, Approves Key Reappointments

Kronox Lab Sciences Approves Unaudited Standalone Results for Quarter Ended June 2025

Kronox Lab Sciences: Board re-appoints Directors, Auditors, and sets AGM Date

Kronox Lab Sciences: Promoter Reclassification Approved; Exchanges Issue Warning for Delayed Disclosure